Colorado vaccine site closed amid reports of adverse events after JNJ COVID-19 shot Published 08 Apr 2021 Full Article
Johnson & Johnson delays COVID-19 vaccine rollout in Europe as US authorities investigate blood clots Proactive Investors 13 Apr 2021 Johnson & Johnson (NYSE:JNJ) said it is delaying the European rollout of its COVID-19 vaccine after it was suspended in the US..